Keryx Partners in Japan See Positive Results From Zerenex

Keryx Biopharmaceuticals said its Japanese partner has seen positive results from an advanced study of a treatment for hyperphosphatemia in end-stage kidney disease patients on dialysis.
The Wall Street Journal